SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?


To: PAL who wrote (3158)12/5/1997 11:02:00 AM
From: Izzy  Read Replies (1) | Respond to of 6136
 
Paul, why would AGPH want to be bought out now? If anytime, wouldn't mid-1998 be better (once the EU sales are going full force)? Seems to me like AGPH is doing just fine where it is. The company is already in bed with JT. Does it really need more partners (it's holding almost 100 million cash isn't it). Doesn't appear that AGPH is hurting for money. And, the stock is on a good run today (finally!!!); glad I bought in at 28 1/2 yesterday but my break-even is still at 41. I'm holding for now. Why do you think Johnson has to go on CNBC Monday? What's the point or issue?



To: PAL who wrote (3158)12/5/1997 4:01:00 PM
From: Max Singer  Respond to of 6136
 
We don't want anyone to buy AGPH at 75. Maybe 150.